{"database": "lobbying", "table": "lobbying_activities", "rows": [[2956602, "c32baa6c-c2ce-4ab2-8f4e-2066beba2c92", "Q1", "HALL, RENDER, KILLIAN, HEATH & LYMAN, P.C.", 17352, "EISENHOWER HEALTH", 2023, "first_quarter", "MMM", "Site-Neutral payment reform; drug pricing legislation; health care regulatory issues; Coronavirus funding and regulatory issues; Medicare sequester and funding.", "HOUSE OF REPRESENTATIVES,SENATE", 0, 0, "2023-04-10T15:45:33-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2956602"], "units": {}, "query_ms": 1.3241580163594335, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}